Feature Channels:

Personalized Medicine

Add to Favorites Subscribe Share
fbshare-Personalized Medicine

Showing results

110 of 531
Newswise: Rutgers Cardiologist Advocates for Personalized Treatment with Aspirin as Primary Prevention in Cardiovascular Disease

Article ID: 719072

Rutgers Cardiologist Advocates for Personalized Treatment with Aspirin as Primary Prevention in Cardiovascular Disease

Rutgers Robert Wood Johnson Medical School

A nationally recognized Rutgers cardiologist recommends that aspirin be used as primary prevention for cardiovascular disease only with select patients, saying that the scientific evidence is too diverse to support a one-size-fits-all approach.

Released:
17-Sep-2019 10:05 AM EDT
Newswise: Cancer Protocols: A New Approach to Predicting Treatment Outcomes

Article ID: 718957

Cancer Protocols: A New Approach to Predicting Treatment Outcomes

Weizmann Institute of Science

Research by the Weizmann Institute of Science's Prof. Yardena Samuels shows that heterogeneity in melanoma tumors prevents effective immune responses

Released:
13-Sep-2019 1:45 PM EDT
logoMOFFITT_2c_RGB.jpg

Article ID: 717865

Moffitt Researchers Develop Model to Personalize Radiation Treatment for Breast Cancer Patients

Moffitt Cancer Center

A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns. However, this same personalized strategy has not translated to radiation therapy, and a one-size-fits-all approach for most patients is still common practice. Moffitt Cancer Center researchers hope to change this mindset for radiation treatment with the development of a genomically-based model that can optimize and personalize a radiation dose to match an individual patient’s needs.

Released:
22-Aug-2019 10:50 AM EDT
Newswise: Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes

Article ID: 717247

Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes

University of California San Diego Health

The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.

Released:
8-Aug-2019 4:50 PM EDT
chp-logo.jpg

Article ID: 716595

CHOP Research Team Redefines the Footprint of Viral Vector Gene Therapy

Children's Hospital of Philadelphia

Building on a track record of developing adeno-associated viral (AAV) vectors as a groundbreaking clinical tool for gene therapy and gene editing, Children’s Hospital of Philadelphia (CHOP) researchers report a more sensitive method for capturing the footprint of AAV vectors—a broad range of sites where the vectors transfer genetic material.

Released:
30-Jul-2019 9:00 AM EDT
Newswise: Pediatricians first in the field to assess how to personalize treatment for hypertension in children

Article ID: 716429

Pediatricians first in the field to assess how to personalize treatment for hypertension in children

University of Texas Health Science Center at Houston

High blood pressure among children is on the rise and a lack of research about how to treat it has left pediatricians trying to make their best guess. That’s until researchers released results of a pioneering study that used a series of personalized trials to identify a preferred therapy for kids – the first step in tackling the problem.

Released:
26-Jul-2019 8:05 AM EDT

Article ID: 716359

Expanding the limits of personalized medicine with high-performance computing

Argonne National Laboratory

Imagine that you have a serious medical condition. Then imagine that when you visit a team of doctors, they could build an identical virtual ‘twin’ of the condition and simulate millions of ways to treat it until they develop an effective treatment. That is the vision of a team of scientists, led by Argonne National Laboratory.

Released:
24-Jul-2019 5:05 PM EDT
Newswise: New technique helps create more personalized therapies for people with hard-to-treat cancers
  • Embargo expired:
    22-Jul-2019 8:00 AM EDT

Article ID: 716062

New technique helps create more personalized therapies for people with hard-to-treat cancers

University of California, Los Angeles (UCLA), Health Sciences

Using an ultra-sensitive and high-throughput isolation technology, UCLA researchers were able to characterize and identify the neoantigens driving the antitumor responses in a patient treated with anti-PD-1 blockade and isolate the T cell receptors responsible for such effect.

Released:
18-Jul-2019 3:05 PM EDT

Showing results

110 of 531

Chat now!